{"url_path":"/sec/inbx/8-k/2026-05-14/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-14","source_url":"https://www.sec.gov/Archives/edgar/data/2007919/0002007919-26-000028-index.html","accession_number":"0002007919-26-000028","cik":"0002007919","ticker":"INBX","issuer_name":"Inhibrx Biosciences, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/2007919/0002007919-26-000028-index.html","primary_entity_key":"0002007919","primary_entity_name":"Inhibrx Biosciences, Inc."},"word_count":79,"has_tables":true,"body_markdown":"Item 9.01.    Financial Statements and Exhibits.\n\n(d) Exhibits.\n\nExhibit No.Description\n\n99.1\n[Press Release issued by Inhibrx Biosciences, Inc. on May 14, 2026](exhibit99103312026.htm)\n\n104Cover Page Interactive Data File (embedded within the Inline XBRL document)\n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\nDate: May 14, 2026\n\nINHIBRX BIOSCIENCES, INC.\n\nBy:/s/ Kelly Deck\n\nName:Kelly Deck\n\nTitle:Chief Financial Officer"}